DKSH, a pharma market-services contractor, has re-upped with Bayer HealthCare to help the drug giant expand its presence in Cambodia, agreeing to handle importation, regulatory clearance and distribution in the Asian nation.
The two have worked together in Asia since 2003, and Bayer says the Swiss DKSH has been deft in porting successful therapies into new and diverse markets.
"Our decision to extend our partnership in Cambodia is based on their broad capabilities and expertise in innovative value-added services, their dedication to quality and compliance as well as their deep market and industry knowledge," Bayer Cambodian Branch Manager Maline Srun said in a statement.
DKSH is counting on the new deal to drive future profitability, affirming the company's reputation as the partner of choice for drugmakers of all sizes looking to wet their feet in new markets. The Asia-focused company operates 150 locations across 13 countries.
Last year, the company raked in about $9.36 billion in sales, boosted by its recent expansion in contract manufacturing and three bolt-on acquisitions DKSH says will help drive further growth.
- read the announcement
- check out DKSH's financials
- read more from FiercePharmaManufacturing